Smartly linked haemato-oncology: excellence in every drop

Advancing patient-centric care in haemato-oncology

Haematologic malignancies are complex, often life-threatening conditions that require urgent and precise diagnosis. Accurate disease characterisation is critical, directly impacting treatment decisions and patient outcomes – especially for the most vulnerable, including children and the elderly.

As a global leader in haematology, Sysmex is committed to supporting patients at every stage of their healthcare journey. Our mission is to empower healthcare professionals with the tools and insights necessary to make timely, informed decisions that enhance patient care.

We offer high-quality diagnostic solutions that support laboratories and clinicians throughout the entire haemato-oncology patient journey. Our expertise extends beyond traditional hematology laboratories, incorporating innovations in clinical flow cytometry, molecular diagnostics, and cytogenetics.

By integrating innovation, quality, and patient-centered care, we enable healthcare professionals to drive better outcomes and redefine excellence in haemato-oncology.

It all starts with a complete blood count (CBC), but there is more to it than meets the eye! Go beyond counts with advanced blood parameters that offer a deeper insight into the physiology of patients.

• Identify immature cells circulating in the periphery
  • Nucleated red blood cells (NRBC) for haematopoietic stress
  • Immature granulocytes (IG) for guiding further tests
• Assess the immune response against infections
  • Evaluate the activation of neutrophils and lymphocytes
• Assess iron availability with the reticulocyte haemoglobin equivalent (RET-He)
  • RET-He can support anaemia diagnostics in leukaemic patients
• Get precise counts in cytopenias - studies have demonstrated
  • Reliable WBC values in severe leucocytopenic samples
  • Accurate platelet count as low as the transfusion threshold
• Be alerted to incidental findings of leukaemia

Combine with AI-powered digital morphology for more precise haematopathology insights.

Comprehensive insights into haematologic malignancies: leukaemia & lymphoma immunophenotyping

• Accurate diagnosis and monitoring of haematologic malignancies require a comprehensive and precise approach. Flow cytometric immunophenotyping plays a critical role in detecting aberrant cell populations, supporting clinicians in making informed treatment decisions. With a wide range of Sysmex CyFlow^TM CE IVD antibody reagents, laboratories can ensure reliable and standardised immunophenotyping analysis.

Cytogenetic and molecular genetic testing solutions for clinical management and research

For patient stratification and treatment decisions, it is crucial to characterise the disease-specific genetic alterations. Today, advanced molecular genetic tools are employed for the precise determination of the blood cancer type, both in routine and clinical research settings. Fluorescence in situ hybridisation (FISH) enables the detection of chromosomal abnormalities.

• CytoCell^® high quality, reliable and easy-to-use DNA probes for FISH for haematological malignancies supporting patient diagnostic and clinical management. Whether IVDR-certified, tri-colour, FAST-protocol or customised FISH, there is a right CytoCell probe to meet your requirements.

Next-generation sequencing (NGS) provides detailed insights into minute genetic mutations and allows monitoring of disease evolution.

• SureSeq^TM NGS panels, library preparation kits and software supporting clinical research on genetic prognosis stratification and measurable residual disease (MRD). Designed to detect even low-frequency variants with confidence in key targets such as NPM1, FLT3-ITD, KMT2A-PTDs, JAK2, BCL2 and BTK.

SureSeq^TM: For Research Use Only. Not for use in diagnostic procedures. CytoCell^®: Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representatives for availability.

Seamless data integration delivers accurate, reproducible, and clinically relevant insights

In haemato-oncology, seamless data integration is key to delivering timely, accurate, and clinically relevant insights. CyFlow WA bridges the gap between haematology and flow cytometry, creating a unified workflow that enhances traceability, standardisation, and result validation. By automating data management, it ensures efficient, reproducible diagnostics, empowering clinicians to make informed decisions with comprehensive, cross-disciplinary insights.